The EPS projection of Amedisys Inc (NASDAQ:AMED) for quarter ended 2016-09-30 is $0.47. A week before, the EPS forecast was $0.47 against target of $0.47, a month earlier. This estimate stood at $0.47 60 days earlier versus forecast of $0.47 90 days earlier, confirming a deviation of 0%.
Amedisys Inc (NASDAQ:AMED) reported that 18 days ago, the positive EPS revisions were 3 and negative revisions at 1.
In last week, the per-share earnings was lowered 0 times and 0 times positively. In last 120, 60, 30 and 90 days the positive revisions were 3, 1, 0 and 1, respectively.
The downgrade of EPS estimates for Amedisys Inc (NASDAQ:AMED) in the preceding 120, 60, 30 and 90 days were 0, 0, 0 and 0, in that order.
As per the latest update, for the quarter closed 1, the EPS estimate of Amedisys Inc (NASDAQ:AMED) was $0.47. This projection was computed after accounting 6 calls. As reported on 2016-05-03 the EPS was $0.33. The change was $-0.01, demonstrating a percentage deviation of -2.94%. The projections confirmed a standard deviation of 0.01.
Quarterly Sales Estimates
For the fiscal 2017, the yearly sales target for Amedisys Inc (NASDAQ:AMED) stands at $383.706 and the median estimate at $383.973. Almost 4 analysts announced their estimates.
The highest estimate is $388.58 while the lowest target is $378.3 showing standard deviation of 4.307%.
As many as 4 analysts released sales estimates reised in upside while 4 reduced sales estimates, demonstrating a deviation of 0%.
In last month, 4 revised sales number projection on upside while 4 lowered the sales target, demonstrating a deviation of 0%.
A quarter ago, 4 hiked sales estimations and 4 reduced sales forecast. Amedisys Inc (NASDAQ:AMED) stated that the change in forecast was 0.335%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...